sinomenine and Cardiovascular-Diseases

sinomenine has been researched along with Cardiovascular-Diseases* in 1 studies

Reviews

1 review(s) available for sinomenine and Cardiovascular-Diseases

ArticleYear
Pharmacological Effects and Mechanisms of Chinese Medicines Modulating NLRP3 Inflammasomes in Ischemic Cardio/Cerebral Vascular Disease.
    The American journal of Chinese medicine, 2018, Volume: 46, Issue:8

    Cardio/cerebral-vascular diseases seriously threaten human health and are the leading cause of death. As such, there is great interest in identifying a potential mechanism that controls the development process of cardio/cerebral vascular diseases. Present studies demonstrate that inflammasomes play an important role in the process of ischemic cardio/cerebral vascular diseases (ICCVDs). Among the pathological process of ICCVDs, inflammasomes activated the sterile inflammatory response that accelerated the development of diseases and aggravated the acute lesion of tissue. As the most thoroughly studied inflammasome, the NLRP3 inflammasome has been proven to be a potential therapeutic target for ICCVDs. In this review, we summarized the mechanisms of Chinese herbal medicine which can affect ICCVDs via the regulation of the NLRP3 inflammasome. Our study discovers that active compounds of Chinese medicines have a negative effect on NLRP3 in different ICCVDs models. Astragaloside IV may influence the receptor of the cell membrane to inhibit NLRP3 activation. Resveratrol, colchicinesis, salvianolic acid B, chrysophanol and sulforaphane may directly damage the formation of NLRP3 by inhibiting ASC or Caspase-1. Most of the active natural compounds can negatively regulate the downstream products of NLRP3 inflammasome such as IL-18 and IL1

    Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Drugs, Chinese Herbal; Humans; Inflammasomes; Molecular Targeted Therapy; Morphinans; NLR Family, Pyrin Domain-Containing 3 Protein; Resveratrol; Spirostans

2018